Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016

Details for Mechanism ID: 16397
Country/Region: Tanzania
Year: 2014
Main Partner: Deloitte Consulting Limited
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $28,974,351 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

The TUNAJALI II program continues to support the scale-up of comprehensive, integrated, and sustainable clinical and community-based HIV/AIDS services in five regions: Njombe, Iringa, Morogoro, Dodoma, and Singida. The program intends to achieve the following results by the end of the program period: improved capacity of local governments to plan; manage and report quality HIV service delivery and support; enhanced capacity of CSOs for comprehensive community-based HIV/AIDS service management and delivery; increased local revenues and resources available for integrated HIV and AIDS care; improved access to quality, integrated and comprehensive HIV care and treatment services; and improved woman and girl child responsive HIV treatment, care and support. The program contributes to the GHI strategy by scaling up services and enhancing local ownership and sustainability. In addition to Pre- ART and ART services, facility services also include the provision of provider-initiated testing and counseling (PITC), laboratory diagnostic services, palliative care, TB/HIV screening and treatment services, management of OIs, cervical cancer screening, FP and RH services, malaria prophylaxis (IPT), PHDP services, and nutritional assessment counseling and support services. Community services include palliative care for PLHIV, PHDP, PLHIV support groups, ART adherence, and patient follow up. TUNAJALI II builds local government and CSO institutional capacities to be able to manage the program and improve gender mainstreaming at all levels. The program also strengthens referral networks and linkages with other HIV/AIDS implementing partners and programs for better outcomes. TUNAJALI II also aligns its services and M&E to national guidelines, standards, and frameworks.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $4,270,509
Care: TB/HIV (HVTB) $500,000
Care: Pediatric Care and Support (PDCS) $228,000
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Testing: HIV Testing and Counseling (HVCT) $1,150,000
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $6,459,338
Treatment: Adult Treatment (HTXS) $14,512,394
Treatment: Pediatric Treatment (PDTX) $1,854,110
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2015 24
GEND_GBV Number of people receiving post-GBV care 2015 24
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 22,729
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2015 13,642
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 67,017
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2015 64,084
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 8,358
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2015 20,587
HTS_TST Aggregated Age/sex: 15+ Female 2015 51,169
HTS_TST Aggregated Age/sex: 15+ Male 2015 28,310
HTS_TST By Test Result: Negative 2015 95,177
HTS_TST By Test Result: Negative 2015 75,610
HTS_TST By Test Result: Negative 2015 92,464
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 160,000
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 79,479
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2015 40,000
HTS_TST Sum of Aggregated Age/Sex <15 2015 22,729
HTS_TST Sum of Aggregated Age/Sex <15 2015 13,642
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 75,375
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 79,479
HTS_TST Sum of Aggregated Age/Sex 15+ 2015 84,671
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 98,104
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 79,479
HTS_TST Sum of Aggregated Age/Sex disaggregates 2015 98,313
HTS_TST Sum of Test Result disaggregates 2015 98,104
HTS_TST Sum of Test Result disaggregates 2015 79,479
HTS_TST Sum of Test Result disaggregates 2015 98,313
HTS_TST_POS By Test Result: Positive 2015 2,927
HTS_TST_POS By Test Result: Positive 2015 3,869
HTS_TST_POS By Test Result: Positive 2015 5,849
LAB_ACC By site support type: Direct Service Delivery (DSD) 2015 3
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2015 3
LAB_ACC Sum of Support Type disaggregates 2015 3
LAB_CAP By clinical laboratories 2015 184
LAB_CAP By Point-of-care testing sites 2015 543
LAB_CAP By site support type: Direct Service Delivery (DSD) 2015 214
LAB_CAP By site support type: Technical Assistance-only (TA) 2015 513
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2015 727
LAB_CAP Sum of Site Support Type disaggregates 2015 727
PMTCT_ARV Life-long ART (including Option B+) 2015 11,048
PMTCT_ARV Life-long ART (including Option B+) 2015 5,989
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 13,340
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2015 6,845
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 3,498
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2015 5,708
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 6,552
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2015 3,622
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 4,496
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2015 2,367
PMTCT_ARV Sum of New and Current disaggregates 2015 11,048
PMTCT_ARV Sum of New and Current disaggregates 2015 5,989
PMTCT_ARV Sum of Regimen Type disaggregates 2015 11,048
PMTCT_ARV Sum of Regimen Type disaggregates 2015 5,989
PMTCT_EID By infants who received a virologic test within 2 months of birth 2015 11,285
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2015 4,863
PMTCT_EID By infants with a positive virologic test result within 12 months of birth 2015 441
PMTCT_EID Number of HIV- positive pregnant women identified during the reporting period (include known HIV-positive women at entry into PMTCT) 2015 20,185
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2015 4,258
PMTCT_EID Sum of Infant Age disaggregates 2015 16,148
PMTCT_STAT By: Known positives at entry 2015 1,609
PMTCT_STAT By: Known positives at entry 2015 897
PMTCT_STAT By: Number of new positives identified 2015 9,121
PMTCT_STAT By: Number of new positives identified 2015 5,009
PMTCT_STAT Number of new ANC and L&D clients 2015 169,786
PMTCT_STAT Number of new ANC and L&D clients 2015 94,032
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 57,240
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2015 93,392
PMTCT_STAT Sum of Positives Status disaggregates 2015 10,730
PMTCT_STAT Sum of Positives Status disaggregates 2015 5,906
SITE_SUPP By program area/support type: Care and Support Direct Service Delivery (DSD) 2015 501
SITE_SUPP By program area/support type: Care and Support Technical Assistance-only (TA) 2015 25
SITE_SUPP By program area/support type: HTC Direct Service Delivery (DSD) 2015 217
SITE_SUPP By program area/support type: HTC Technical Assistance-only (TA) 2015 345
SITE_SUPP By program area/support type: Lab Direct Service Delivery (DSD) 2015 214
SITE_SUPP By program area/support type: Lab Technical Assistance-only (TA) 2015 107
SITE_SUPP By program area/support type: OVC Direct Service Delivery (DSD) 2015 1
SITE_SUPP By program area/support type: PMTCT Direct Service Delivery (DSD) 2015 167
SITE_SUPP By program area/support type: PMTCT Technical Assistance-only (TA) 2015 944
SITE_SUPP By program area/support type: Treatment Direct Service Delivery (DSD) 2015 223
SITE_SUPP Number of unique sites supported by PEPFAR 2015 1,394
TX_CURR Aggregated Age/Sex: <1 Female 2015 1,740
TX_CURR Aggregated Age/Sex: <1 Male 2015 821
TX_CURR Aggregated Age/Sex: <15 Female 2015 3,812
TX_CURR Aggregated Age/Sex: <15 Male 2015 1,920
TX_CURR Aggregated Age/Sex: 15+ Female 2015 64,778
TX_CURR Aggregated Age/Sex: 15+ Male 2015 32,782
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2015 106,684
TX_CURR Sum of Aggregated Age/Sex <15 2015 5,732
TX_CURR Sum of Aggregated Age/Sex 15+ 2015 97,560
TX_CURR Sum of Aggregated Age/Sex disaggregates 2015 103,292
TX_NEW Aggregated Grouping by Age: <1 Male 2015 153
TX_NEW Aggregated Grouping by Age/Sex: <1 Female 2015 186
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2015 869
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2015 514
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2015 12,607
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2015 6,497
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2015 19,817
TX_NEW Pregnancy status 2015 4,442
TX_NEW Sum of Aggregated Age/Sex disaggregates 2015 20,487
Cross Cutting Budget Categories and Known Amounts Total: $3,329,712
Human Resources for Health $1,874,723
Renovation $540,000
Motor Vehicles: Purchased $504,192
Gender: Gender Based Violence (GBV) $36,161
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Gender: Gender Equality $144,636
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Water $230,000
Key Issues Identified in Mechanism
enumerations.Malaria (PMI)
Child Survival Activities
Mobile Populations
Safe Motherhood
Tuberculosis
Family Planning